GET THE APP

..

Journal of Cancer Clinical Trials

ISSN: 2577-0535

Open Access

Firmbach Daniel

Department of Medical Oncology, University Hospital of Besançon, boulevard Fleming, 25000 Besançon, France

Publications
  • Mini Review   
    Integrating Biomarkers into Clinical Practice: A Roadmap for Effective Cancer Management
    Author(s): Firmbach Daniel*

    Ultrasensitive DNA-biomacromolecule refers to a system or technology that can detect and analyze DNA molecules with extremely high sensitivity. DNA, as the genetic material of living organisms, plays a vital role in various biological processes and is often used for diagnostic and research purposes. Ultrasensitive DNA-biomacromolecule technologies are designed to detect and measure minute quantities of DNA molecules present in a sample. These technologies employ various detection methods, such as fluorescence, electrochemical sensing, nanopore sequencing, or amplification techniques like polymerase chain reaction. By leveraging these techniques, scientists can achieve highly sensitive and accurate detection of DNA molecules, even at very low concentrations... Read More»
    DOI: 10.37421/2577-0535.2023.8.223

    Abstract HTML PDF

Google Scholar citation report
Citations: 95

Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report

Journal of Cancer Clinical Trials peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward